Sarah K. Lawrence

The Metabolic Drug-Drug Interaction Profile of Dabrafenib: In Vitro Investigations and Quantitative Extrapolation of the P450-Mediated DDI Risk

Sarah K. Lawrence, Dung N. Nguyen, Chet Bowen et al. · Drug Metabolism and Disposition · 2014 · 52 citations

Prediction of the Transporter-Mediated Drug-Drug Interaction Potential of Dabrafenib and Its Major Circulating Metabolites

Harma Ellens, Marta Johnson, Sarah K. Lawrence et al. · Drug Metabolism and Disposition · 2017 · 20 citations

N-Alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists

Yonghui Wang, Zining Wu, Brian F. Guida et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 17 citations · Full text

Medicinal Chemistry, Medicine, Mechanism Of Action +4

2-Aminomethyl piperidines as novel urotensin-II receptor antagonists

Jian Jin, Yonghui Wang, Feng Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 15 citations · Full text

Molecular Pharmacology, Medicine, 2-Aminomethyl Piperidines +6